TCM
PMVP icon

Tang Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

Tang Capital Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.26M Sell
4,245,085
-694,915
-14% -$884K 0.27% 35
2025
Q4 		$6.17M Buy
4,940,000
+154,799
+3% +$207K 0.31% 54
2025
Q3 		$6.7M Buy
+4,785,201
New +$6.62M 0.26% 82

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tang Capital Management's PMVP Position: Q1 2026 in Review

Tang Capital Management reduced its PMV Pharmaceuticals (PMVP) stake by 14% in Q1 2026, selling an estimated $884K and leaving 4,245,085 shares worth $5.26M. The position accounts for 0.27% of the portfolio, ranked #35.

Tang Capital Management first reported a position in PMVP in Q3 2025 and has held it in 3 quarters since. The position peaked at $6.7M in Q3 2025. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Tang Capital Management held 4,245,085 shares of PMV Pharmaceuticals worth $5.26M as of Q1 2026.
  • Tang Capital Management sold 694,915 PMV Pharmaceuticals shares in Q1 2026, an estimated $884K.
  • PMV Pharmaceuticals made up 0.27% of Tang Capital Management's portfolio in Q1 2026, its #35 holding.
  • Tang Capital Management first reported a position in PMV Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Tang Capital Management's PMV Pharmaceuticals position peaked at $6.7M in Q3 2025.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Tang Capital Management's 13F filing for Q1 2026, filed 15 May 2026.